GlassScriptPhysician profile
Lisa Samson
NPI 1093810517
$5,279.53
in general payments reported to CMS, 2019-2025
23 companies · $1,129 in 2025
The $1,129 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $908 · 2022: $1,090 · 2023: $907 · 2024: $1,245 · 2025: $1,129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,281.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $744.32 | 2021-2025 | Bimzelx, Cimzia |
| Lilly USA, LLC | $719.74 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Abbvie INC. | $683.05 | 2021-2025 | |
| Janssen Biotech, INC. | $510.11 | 2021-2025 | Tremfya, Stelara, Simponi |
| Incyte Corporation | $461.87 | 2021-2025 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $367.25 | 2023-2025 | Sotyktu, Sprycel |
| Leo Pharma INC. | $229.35 | 2021-2024 | Adbry |
| Regeneron Healthcare Solutions, INC. | $203.84 | 2021-2024 | Dupixent |
| Sun Pharmaceutical Industries INC. | $189.36 | 2023-2025 | Ilumya, Absorica Ld, Winlevi |
| Arcutis Biotherapeutics, INC. | $188.86 | 2023-2025 | Zoryve |
| Vyne Pharmaceuticals INC. | $175.93 | 2021 | |
| Pfizer INC. | $169.06 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $150.12 | 2021-2025 | |
| Genzyme Corporation | $101.12 | 2021-2024 | |
| Galderma Laboratories, L.P. | $88.88 | 2021-2025 | Nemluvio, Aklief |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $79.41 | 2024-2025 | Otezla |
| Organon LLC | $59.50 | 2025 | |
| Solta Medical, A Division of Bausch Health US, LLC | $42.49 | 2025 | |
| Celgene Corporation | $30.15 | 2024 | Sotyktu |
| Dermavant Sciences, INC. | $27.33 | 2023 | Vtama |
| Nobelpharma America, LLC | $21.38 | 2025 | |
| Biofrontera INC. | $21.12 | 2022 | |
| Henry Schein, INC. | $15.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Samson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.